BG Medicine, Inc. (BGMD) Posts Narrower than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Join SI Premium – FREE
BG Medicine, Inc. (NASDAQ: BGMD) reported Q2 loss of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $221 thousand versus the consensus estimate of $170 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
